EDGAR Filing Documents for 0001104659-17-038433

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001104659-17-038433

Filing Date

2017-06-09

Accepted

2017-06-09 16:33:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a17-14896_1s3.htm	S-3	515934
2	EX-1.2	a17-14896_1ex1d2.htm	EX-1.2	250589
3	EX-4.4	a17-14896_1ex4d4.htm	EX-4.4	450928
4	EX-5.1	a17-14896_1ex5d1.htm	EX-5.1	25092
5	EX-5.2	a17-14896_1ex5d2.htm	EX-5.2	12011
6	EX-12.1	a17-14896_1ex12d1.htm	EX-12.1	84521
7	EX-23.1	a17-14896_1ex23d1.htm	EX-23.1	2710
8	GRAPHIC	g148961bmi001.gif	GRAPHIC	8126
9	GRAPHIC	g148961bei001.gif	GRAPHIC	6986
10	GRAPHIC	g148961kki001.gif	GRAPHIC	3813
11	GRAPHIC	g148961kmi001.gif	GRAPHIC	3813
12	GRAPHIC	g148961bui001.gif	GRAPHIC	5383
13	GRAPHIC	g148961bwi001.gif	GRAPHIC	5383
	Complete submission text file	0001104659-17-038433.txt		1389885

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333

Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505

Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)